Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart

Journal of Nuclear Medicine

Volumn 40, Issue 2, 1999, Pages 224-231

  Merlet, Pascal ^a   Pouillart, Frédéric ^b   Dubois Randé, Jean Luc ^b   Delahaye, Nicolas ^b   Fumey, Roselyne ^b   Castaigne, Alain ^b   Syrota, André ^b  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^b NONE

Author keywords

Captopril; Idiopathic dilated cardiomyopathy; Metaiodobenzylguanidine; Metoprolol; Norepinephrine; Prognosis; Radionuclide left ventricular ejection fraction; Uptake 1

Indexed keywords

(3 IODOBENZYL)GUANIDINE; IODINE 123;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART DILATATION; HEART FAILURE; HEART INNERVATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SCINTISCANNING; HUMAN; ISOTOPE LABELING; MALE; PRIORITY JOURNAL; SYMPATHETIC INNERVATION; SYMPATHETIC TONE;

3-IODOBENZYLGUANIDINE; ADRENERGIC BETA-ANTAGONISTS; ADULT; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MALE; METOPROLOL; NEURONS; NOREPINEPHRINE; OXYGEN CONSUMPTION; RADIONUCLIDE ANGIOGRAPHY; RADIOPHARMACEUTICALS; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM;

EID: 0032983539     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Petch MC, Nayler WG. Uptake of catecholamines by human cardiac muscle in vitro. Br Heart J. 1979;41:3.16-339.
2. Spann JF, Chidsey CA, Pool PE, Braunwald E. Mechanism of norepinephrine depletion in experimental heart failure produced by aortic constriction in the guinea pig. Circ Res. 1965;17:312-321.
3. Shofer J, Tews A, Rühwedel H, Reimitz PE, Mathey DG. Myocardial noradrenaline content: a factor not considered up to now for the prognosis of patients with dilated cardiomyopathy. Z Kardiol. 1989;78:366-377.
4. Wieland DM, Brown LE, Rogers L, et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med. 1981;22:22-31.
5. Dac MW, De Marco T, Botvinick EH, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts - implications for clinical studies. J Nucl Med. 1992;33:1444-1450.
6. Glowniak JV, Turner FE, Gray LL, Palac RT, Lagunas-Solar MC, Woodward WR. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med. 1989;30:1182-1191.
7. Schofer J, Spielmann R, Schuchert A, Weber K, Schüter M. Iodine-123 metaiodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1988;12:1252-1258.
8. Merlet P, Dubois-Randé JL, Adnot S, et al. Myocardial β-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol. 1992;19:10-16.
9. Merlet P, Valette H, Dubois-Randé JL. et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471-477.
10. Heilbrunn SM, Shah P, Bristow MR, Valantine HA, Ginsburg R, Fowler MB. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation. 1989;79:483-490.
11. Waagstein F, Bristow MR, Swedberg K, et al. for the Metoprolol in Dilated Cardiomyopathy Trial Study Group. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 1993;342:1441-1446.
12. The Cardiac Insufficiency Bisoprolol Study (CIBIS) Investigators. A randomized trial of β-blockade in heart failure. Circulation. 1994;90:1755-1773.
13. Packer M, Bristow MR, Cohn JN, et al. for the US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl Med. 1996;334:1349-1355.
14. Engelmeier RS, O'Connell JB, Walsh R, Rad N, Seanlon PJ, Gunnar RM. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randormized, placebo-controlled trial. Circulation. 1985;72:536-546.
15. CONSENSUS Trial Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl Med. 1987;316:1429-1435.
16. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
17. SOLVD II Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med. 1992;32:685-691.
18. Pfeffer MA, Braunwald E, Moyé LA, et al. on behalf of the SAVE Investigators Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992;327:669-677.
19. Glowniak J, Kilty J, Amara S, Hoffman BJ, Turner FE. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. J Nucl Med. 1993;34:1140-1146.
20. Chidsey CA, Braunwald E, Morrow AG. Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure. Am J Med. 1965;39:442-451.
21. Swedberg K, Viquerat C, Rouleau JL, et al. Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure. Am J Cardiol. 1984;54:783-786.
22. Hasking GJ, Esler MD, Jenning GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615-621.
23. Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler MD. Cardiac sympathetic nervous activity in congestive heart failure: evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation. 1993;88:136-145.
24. Rose C, Burgess JH, Cousineau D. Tracer norepinephrine kinetics in coronary circulation of patients with heart failure secondary to chronic pressure and volume overload. J Clin Invest. 1985;76:740-747.
25. Sandoval AB, Gilbert EM, Rose CP, Bristow MB. Cardiac norepinephrine uptake and release is decreased in dilated cardiomyopathy [abstract]. Circulation. 1989:80(suppl II):393.
26. Fisher JE, Horst WD, Kopin IJ. Norepinephrine metabolism in hypertrophied rat heart. Nature (London). 1965;207:951-953.
27. Böhm M, La Rosée K, Schwinge RH, Erdmunn E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol. 1995;25:146-153.
28. Eisenhofer G, Friberg P, Rundqvist B, et al. Sympathetic nerve function in congestive heart failure. Circulation. 1996;93:1667-1676.
29. Henderson EB, Kahn JK, Corbelt JR, et al. Abnormal I-123 myocardial washout and distribution may reflect myocardial adrenergic derangement in patient with congestive heart cardiomyopathy. Circulation. 1988;78:1192-1199.
30. Imamura Y, Ando H, Ashihara T, Fukuyama T. Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload. J Am Coll Cardiol. 1996;28:371-375.
31. Levy MN, Blattberg H. The influence of cocaine and desipramine on the cardiac responses to exogenous and endogenous norepinephrine. Eur J Pharmacol. 1978:48:37-49.
32. Masuda Y, Levy MN. The effects of neuronal uptake blockade on the cardiac responses to sympathetic nerve stimulation and norepinephrine infusion in anesthezied dogs. J Autonom Nerv Syst. 1984;10:1-17.
33. Beau SL, Saffitz JE. Transmural heterogeneity of norepinephrine uptake in failing human hearts. J Am Coll Cardiol. 1994;23:579-585.
34. Francis GS. Modulation of peripheral sympathetic nerve transmission. J Am Coll Cardiol. 1988;12:250-254.
35. Khairallah PA. Action of angiotensin on adrenergic nerve endings: inhibition of norepinephrine uptake. Fed Proc. 1972;31:1151-1357.
36. Schwaiger M, Hutchkins GD. Kalff V, et al. Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography. J Clin Invest. 1991;87:1681-1690.
37. Eichhorn EJ, Bedotto JB, Malloy CR, et al. Effect of β-adrenergic blockade on myocardial function and energetics in congestive heart failure. Circulation. 1990:82:473-483.
38. Woodley SL, Gilbert EM, Anderson JL, et al. β-blockade with hucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation. 1991;84:2426-2441.
39. Eichhorn EJ, McGhie A, Bedotto JB, et al. Effects of hucindolol on neurohormonal activation in congestive heart failure. Am J Cardiol. 1991;67:67-73.
40. Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med. 1997;38: 1085-1089.